When was Cambrium founded?

Cambrium was founded in 2020 and raised its 1st funding round 3 years after it was founded.

Where is Cambrium located?

Cambrium is headquartered in Berlin, Germany.

Which legal entities is Cambrium associated with?

Cambrium is associated with Cambrium GmbH and 1 other.

How many employees does Cambrium have?

As of May 31, 2026, the latest employee count at Cambrium is 26.

Is Cambrium a funded company?

Cambrium is a funded company, having raised a total of $11.6M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Oct 31, 2023.

When was the latest funding round of Cambrium?

Cambrium's latest funding was a $***** Seed round on Nov 05, 2024, with participation from 2 investors.

Where does Cambrium rank among its competitors?

Cambrium ranks 4th amongst 30 active competitors, of which 10 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Avisi Technologies, which secured $10.7M in Feb, 2026.

Who are the top competitors of Cambrium?

Cambrium's top competitors include RevBio, Avisi Technologies and ParaGen Technologies. Among them, Avisi Technologies secured the most recent funding round in February, 2026.

Cambrium - 2026 Company Profile, Funding, Competitors & Financials

Company Details

Manufacturer of engineered enzymes polymers and peptides for industrial applications. These molecular systems are designed to provide specific performance characteristics for materials used in sectors including apparel footwear personal care mobility and construction. The production process utilizes molecular intelligence to predict molecular behavior and living systems to synthesize materials. These products serve as components for foams and protective coatings across various manufacturing industries.

Website: www.cambrium.bio/
Social
Email ID: *****@cambrium.bio
Phone Number: +49 **********

Key Metrics

Founded Year

2020

Location

Berlin, Germany

Stage

Seed

Total Funding

$11.6M in 2 rounds

Latest Funding Round

Seed, Nov 05, 2024, $*****

Investors

Essential Capital & 7 more

Ranked

4^th among 30 active competitors

Employee Count

26 as on May 31, 2026

Similar Companies

RevBio & 36 more

View Cambrium's full profile

Cambrium is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Cambrium GmbH CIN: F1103_HRB220753B , Germany, Active	Sep 03, 2020	-	-
Cambrium GmbH CIN: HRB220753 , Germany, Active	Sep 02, 2020	-	-

Cambrium has raised a total funding of $11.6M over 2 rounds. Its first funding round was on Oct 31, 2023. Its latest funding round was a Seed round on Nov 05, 2024 for $*****. 2 investors participated in its latest round. Cambrium has 7 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Cambrium:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 05, 2024	5332048	Seed	2347757	9808771	5008703	9865601
Oct 31, 2023	2486972	Seed	2569506	3533282	Essential Capital	SNR & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of Cambrium's funding rounds and investors

Cambrium's employee count trend

Cambrium has 26 employees as of May 26. Here is Cambrium's employee count trend over the years:

Uncover Cambrium's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cambrium include RevBio, Avisi Technologies and ParaGen Technologies. Here is the list of Top 10 competitors of Cambrium, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	RevBio 2014, Lowell (United States), Series B	Developer of synthetic adhesive used for bone/dental repair	$27.5M	Pacific Dental Services, HHS & 3 others	62/100
2nd	Avisi Technologies 2017, Philadelphia (United States), Series A	Developer of nano-materials	$15.7M	MedVenture Partners, MedTech Innovator & 20 others	61/100
3rd	ParaGen Technologies 2016, Columbus (United States), Series A	Developer of tissue engineering technologies	$11.6M	Ikove Capital Partners, JointJourney & 2 others	45/100
4th	Cambrium 2020, Berlin (Germany), Seed	Manufacturer of engineered enzymes polymers and peptides for industrial applications	$11.6M	HOF Capital, Valor Equity Partners & 6 others	40/100
5th	Helicoid Industries 2019, Indio (United States), Seed	Manufacturer of composite materials and components using this helicoid structure	$2.43M	Cleantech Open, OSTI	36/100
6th	Dianomi Therapeutics 2017, Madison (United States), Series A	Developer of therapies for treating inflammatory diseases	$3M	Ligand Pharmaceuticals, HHS	35/100
7th	ATS Laboratories 2012, Norfolk (United States), Acquired	Developer of tissue mimicking platform	-	-	34/100
8th	OsteoNovus 2013, Toledo (United States), Seed	Provider of biomimetic materials to support and regenerate bone	$3.57M	-	32/100
9th	BioRegen 2008, Changzhou (China), Series A	Developer of bio-materials for various therapeutic indications	-	Eight Roads Ventures, F-Prime Capital & 3 others	31/100
10th	PHOMI MCM Group 2010, China, Funding Raised	Provider of modified soil-based materials	-	Haihui Investment	31/100